Rewalk Robotics (STU:2RW) EV-to-EBIT : -0.64 (As of May. 20, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Rewalk Robotics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Rewalk Robotics's Enterprise Value is €15.24 Mil. Rewalk Robotics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-23.81 Mil. Therefore, Rewalk Robotics's EV-to-EBIT for today is -0.64.

The historical rank and industry rank for Rewalk Robotics's EV-to-EBIT or its related term are showing as below:

STU:2RW' s EV-to-EBIT Range Over the Past 10 Years
Min: -27.35 Med: -0.79 Max: 2.92
Current: -1.03

During the past 12 years, the highest EV-to-EBIT of Rewalk Robotics was 2.92. The lowest was -27.35. And the median was -0.79.

STU:2RW's EV-to-EBIT is ranked worse than
100% of 457 companies
in the Medical Devices & Instruments industry
Industry Median: 20.37 vs STU:2RW: -1.03

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Rewalk Robotics's Enterprise Value for the quarter that ended in Mar. 2024 was €0.00 Mil. Rewalk Robotics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-23.81 Mil. Rewalk Robotics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was %.

Rewalk Robotics EV-to-EBIT Historical Data

The historical data trend for Rewalk Robotics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rewalk Robotics EV-to-EBIT Chart

Rewalk Robotics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-0.60

-1.22

0.82

1.12

-0.87

Rewalk Robotics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															0.93	1.07	-0.67	-0.87	-

Competitive Comparison of Rewalk Robotics's EV-to-EBIT

For the Medical Devices subindustry, Rewalk Robotics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rewalk Robotics's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rewalk Robotics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Rewalk Robotics's EV-to-EBIT falls into.

Rewalk Robotics EV-to-EBIT Calculation

Rewalk Robotics's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	15.235	/	-23.813
	=	-0.64

Rewalk Robotics's current Enterprise Value is €15.24 Mil.
Rewalk Robotics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-23.81 Mil.

Rewalk Robotics (STU:2RW) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Rewalk Robotics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-23.813	/	0
	=	%

Rewalk Robotics's Enterprise Value for the quarter that ended in Mar. 2024 was €0.00 Mil.
Rewalk Robotics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-23.81 Mil.

Rewalk Robotics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Rewalk Robotics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Rewalk Robotics (STU:2RW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rewalk Robotics Ltd (STU:2RW) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

RWLK:USA 2RW:Germany

Address

3 Hatnufa Street, P.O. Box 161, Floor 6, Yokneam Ilit, ISR, 2069203

Website

https://www.rewalk.com

ReWalk Robotics Ltd is an Israel based medical device company. It is engaged in designing, developing and commercializing the Rewalk systems which are exoskeletons allowing wheelchair-bound individuals to stand and walk once again. It offers two systems, ReWalk Personal which is designed for every day and all day use by individuals at home and in their communities and is custom-fit for each user; and ReWalk Rehabilitation which is designed for the clinical rehabilitation environment where it provides the user with valuable training exercise and therapy. The company generates maximum revenue from the United States and Europe.

Rewalk Robotics (STU:2RW) Headlines

No Headlines